A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips TJ, Lublin FD, Giovannoni G, Wajgt A, et al. N Engl J Med. 2006 Mar 2; 354(9):899-910. PMID: 16510744. Abstract CommentRecommendBookmarkWatch